Eric Poma
Vorstandsvorsitzender bei MOLECULAR TEMPLATES, INC.
Vermögen: 29 611 $ am 30.04.2024
Aktive Positionen von Eric Poma
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MOLECULAR TEMPLATES, INC. | Direktor/Vorstandsmitglied | 01.01.2000 | - |
Vorstandsvorsitzender | 01.01.2000 | - | |
Technik-/Wissenschafts-/F&E-Leiter | 01.01.2000 | - | |
Gründer | 01.01.2000 | - | |
Molecular Templates OpCo, Inc.
Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Molecular Templates OpCo, Inc. provides medical services. The company is headquartered in Austin, TX. | Direktor/Vorstandsmitglied | - | - |
Vorstandsvorsitzender | - | - |
Karriereverlauf von Eric Poma
Ehemalige bekannte Positionen von Eric Poma
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 01.01.2001 | - |
Innovive Pharmaceuticals, Inc.
Innovive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is developing compounds for the treatment of cancer. It currently have four products in development; INNO-406, tamibarotene, INNO-206 and INNO-406. The Group operates in the United States of America. | Corporate Officer/Principal | 01.03.2005 | - |
Unternehmenssekretär | 01.03.2005 | 25.10.2013 |
Ausbildung von Eric Poma
The Leonard N Stern School of Business | Masters Business Admin |
University of North Carolina at Chapel Hill | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Operativ
Corporate Officer/Principal | 2 |
Director/Board Member | 2 |
Chief Executive Officer | 2 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
MOLECULAR TEMPLATES, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Innovive Pharmaceuticals, Inc.
Innovive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is developing compounds for the treatment of cancer. It currently have four products in development; INNO-406, tamibarotene, INNO-206 and INNO-406. The Group operates in the United States of America. | Health Technology |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
Molecular Templates OpCo, Inc.
Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Molecular Templates OpCo, Inc. provides medical services. The company is headquartered in Austin, TX. | Finance |